NLRP3 and type 2 diabetes mellitus: In a murine model of type 2 diabetes, EGCG improved high-fat-diet-induced glucose tolerance and prevented NLRP3-inflammasome-dependent inflammation suggesting that EGCG as an inhibitor of NLRP3 inflammasome activation could improve glucose tolerance [302].